Disposable Bioreactors Based on Wave Agitation Technology - Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes. - BioPharm

ADVERTISEMENT

Disposable Bioreactors Based on Wave Agitation Technology
Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes.


BioPharm International


DIANA MARJANOVIC is a product manager of disposable bioreactors at Sartorius AG, Switzerland. Gerhard Greller is a scientist in process development, biotechnology, at Sartorius AG, Germany.

References

1. L. Stryer L. Biochemistry, 4th ed. New York (NY): W.H. Freeman and Company; 1995.

2. Wurm F. Nature Biotech 2004;22: 13–98.

3. Sandig V. et al. Mammalian cells. In: Gelissen G., editor. Production of recombinant proteins. (Wiley-VCH; 2005)

4. Weber W. et al. Catching the Wave: The BEVS and the Biowave. Novartis Pharma Research, Switzerland.

5. Eibl D. and Eibl R. BioWorld 2005; 3:1–2 (Supplement BioteCHnet)

6. Pierce, Bioprocessing J 2004; 3: 51–56.

7. Ling et al., Biotechnol Prog 2003; 19(1), 158–62

8. Weber W. et al. Cytotechn 2002; 38: 77–85.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here